Novozymatic BV
Novozymatic (BV) is a company in Kapellen, active in manufacture of basic pharmaceutical products, founded in 2021. Financial year 2025: gross margin -€55,561, profit -€98,442, equity -€352,246.
2 warnings: negative equity, three consecutive years of losses1 serious, 1 point of attentionShowHide
- Explained →
Negative equity. Equity was € -352,246 in financial year 2025. Debts exceed what the company owns; the board must in principle follow the alarm bell procedure.
Source: NBB, 2025 annual accounts - Explained →
Three consecutive years of losses. Loss in 2023, 2024, 2025 (€ -98,442 in 2025).
Source: NBB, annual accounts 2023 to 2025
Figures for Novozymatic, 2025NBB · micro format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about Novozymatic
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Annual accounts 2024 filed
- Annual accounts 2023 filed
- Incorporated as besloten vennootschap
Activities NACE-BEL 2025
21.100Manufacture of basic pharmaceutical productsMain activity21.201Manufacture of pharmaceutical preparations46.460Wholesale of pharmaceutical and medical goods64.210Activities of holding companies70.200Business and other management consultancy activities82.100Office administrative and support activities
Establishments 1
- Kasteeldreef 38, 2950 Kapellen · since 19/01/20212.314.685.165
Publications in the Belgian Official Gazette 1 publication
- 21/01/2021Incorporation and articlesOprichting (nieuwe rechtspersoon, opening bijkantoor, enz...)Deed (pdf)
To the publication → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more